Q1 2025 Quantum-Si Inc Earnings Call Transcript
Key Points
- Quantum-Si Inc (QSI) reported a significant 84% increase in first-quarter revenue compared to the same period in 2024, reaching $842,000.
- The company successfully launched the Platinum Pro system and completed its first customer sales, marking a key milestone in their commercial adoption strategy.
- Quantum-Si Inc (QSI) has expanded its international presence with 23 distribution partners, showing strong performance and interest in international markets.
- The company remains on track to launch its version 4 Sequencing Kit in the third quarter of 2025, which is expected to enhance proteome coverage and amino acid detection.
- Quantum-Si Inc (QSI) has a strong balance sheet with $232.6 million in cash and cash equivalents, providing financial runway into the second half of 2027.
- The company experienced a slowdown in new instrument purchases in the US academic market due to uncertainties related to NIH funding and indirect cost caps.
- First-quarter revenue, although increased, was slightly below the company's expectations.
- Operating expenses increased to $25.6 million in Q1 2025 from $23.6 million in Q1 2024, indicating rising costs.
- The company faces potential impacts from evolving tariffs, which could affect inventory acquisition costs and sales channels outside the United States.
- Quantum-Si Inc (QSI) is unable to provide clear top-line financial guidance due to ongoing uncertainties in the NIH funding environment.
Good day and thank you for standing by. Welcome to the Quantum-Si first-quarter 2025 earnings call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to turn the conference over to today's speaker, Katherine Atkinson. Please go ahead.
Good afternoon, everyone, and thank you for joining us. Earlier today, Quantum-Si released financial results for the first quarter ended March 31, 2025. A copy of the press release is available on the company's website. Joining me today are Jeff Hawkins, our President and Chief Executive Officer; as well as Jeff Keyes, our Chief Financial Officer.
Before we begin, I would like to remind you that management will be making certain forward-looking statements within the meaning of federal security laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Additional information regarding these
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
